Buprenorphine Sublingual

FDA Drug Profile — Buprenorphine Sublingual

Buprenorphine Sublingual is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Buprenorphine Sublingual. Available dosage form: tablet.

Drug details

Generic Name
Buprenorphine Sublingual
Brand Names
Buprenorphine Sublingual
Application Number
ANDA201760
Sponsor
Direct_Rx
NDC Codes
1
Dosage Forms
TABLET
Routes
SUBLINGUAL
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE

Indications and Usage

Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.